Cassia Cinnamon for Glucose Uptake in Young Women

March 3, 2022 updated by: Baylor University

Cassia Cinnamon and Acute Endurance Exercise for the Enhancement of Glucose Uptake in Healthy Young Women

The purpose of this study was to compare the acute effects of 5g of Cassia cinnamon, 50 minutes of endurance exercise performed at 70% of the heart rate reserve (correlated to VO2max), and 5g of cellulose placebo on blood glucose, serum insulin and insulin sensitivity following an oral glucose tolerance test 3 hours after administration of each intervention.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Texas
      • Waco, Texas, United States, 76798
        • Baylor University Department of Health, Human Performance, and Recreation

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 30 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Sedentary
  • BMI: 27-45
  • DXA body fat % greater than 30%
  • 18-30 years of age
  • Healthy
  • From the Baylor University campus and surrounding community
  • Regular sleep habits

Exclusion Criteria:

  • Not regular users of any species of cinnamon
  • Not diagnosed with any metabolic disorder or chronic medical condition
  • Not taking prescription medications for 2 months before the study
  • Not taking ergogenic aids for 2 months before the study
  • Not taking oral contraceptives for 2 months before the study
  • No IUD placed for 2 months before the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 5g Cassia cinnamon
Experimental treatment group
Dietary supplement: Cassia cinnamon
5g encapsulated ground bark administered once in experimental session
Other Names:
  • Brand: Nature's Bounty
Active Comparator: 50 minutes endurnace exercise
Endurance exercise treatment known to influence blood glucose
Procedure: 50 minutes exercise
50 minutes treadmill endurance exercise at 70% of the heart rate reserve (correlated to VO2max)
Placebo Comparator: 5g Cellulose
Placebo equivalent in weight and appearance to experimental treatment
Dietary supplement: Cellulose Powder
5g encapsulated powder administered during placebo experimental session

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Blood Glucose
Time Frame: Baseline, 0, 30, 60, 90 and 120 minutes following OGTT
Baseline, 0, 30, 60, 90 and 120 minutes following OGTT

Secondary Outcome Measures

Outcome Measure
Time Frame
Serum Insulin
Time Frame: Baseline, 0, 30, 60, 90 and 120 minutes following OGTT
Baseline, 0, 30, 60, 90 and 120 minutes following OGTT

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Baylor University

Investigators

  • Study Chair: Darryn S Willoughby, Ph.D., Baylor University
  • Principal Investigator: Jean L Gutierrez, Ph.D., Baylor University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2008

Primary Completion (Actual)

May 1, 2009

Study Completion (Actual)

May 1, 2009

Study Registration Dates

First Submitted

August 3, 2009

First Submitted That Met QC Criteria

August 3, 2009

First Posted (Estimate)

August 4, 2009

Study Record Updates

Last Update Posted (Actual)

March 17, 2022

Last Update Submitted That Met QC Criteria

March 3, 2022

Last Verified

March 1, 2022

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • BaylorU_Cassia_Women

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Insulin Resistance

Clinical Trials on Cassia cinnamon

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Romania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe